In fact, anti‐TNF‐α agents have been used in treatment of vitiligo with uncertain results, even if in vivo studies demonstrated that TNF‐α inhibits differentiation of melanocytes from stem cells.5 The gene discussed is TNF; the disease is vitiligo.